naratriptan has been researched along with berotek in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| de Souza, AS; de Souza, RF; Guzzo, CR | 1 |
2 other study(ies) available for naratriptan and berotek
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationships, molecular docking and molecular dynamics simulations reveal drug repurposing candidates as potent SARS-CoV-2 main protease inhibitors.
Topics: Acarbose; Angiotensin Amide; Antiviral Agents; Dihydrostreptomycin Sulfate; Drug Repositioning; Enviomycin; Fenoterol; Molecular Docking Simulation; Molecular Dynamics Simulation; Protease Inhibitors; Quantitative Structure-Activity Relationship; SARS-CoV-2 | 2022 |